Abstract
Oligodendrocyte degeneration is a hallmark of multiple sclerosis pathology, and protecting oligodendrocytes and myelin is likely to be of clinical relevance. Traditionally, oligodendrocyte and myelin degeneration are viewed as a direct consequence of an inflammatory attack, but metabolic defects might be equally important. Appropriate animal models to study the interplay of inflammation and metabolic injury are, therefore, needed. Here, we describe that in spite of its immunosuppressive effects, a continuous intoxication with cuprizone allows the induction of active experimental autoimmune encephalomyelitis (EAE) by myelin oligodendrocyte glycoprotein (MOG35–55) immunization. Although the clinical severity of EAE is ameliorated in cuprizone-intoxicated mice, the recruitment of granulocytes, and especially, CD3+ lymphocytes into the forebrain is triggered by the cuprizone insult. Such combined lesions are further characterized by oligodendrocyte apoptosis and microglia activation, closely mimicking type III multiple sclerosis lesions. In summary, we provide a protocol that allows to study the direct interplay of immune-mediated and metabolic oligodendrocyte injury and its consequences for the cerebral white and grey matters.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baertling F, Kokozidou M, Pufe T, Clarner T, Windoffer R, Wruck CJ, Brandenburg LO, Beyer C, Kipp M (2010) ADAM12 is expressed by astrocytes during experimental demyelination. Brain Res 1326:1–14. https://doi.org/10.1016/j.brainres.2010.02.049
Bandrowski A, Brush M, Grethe JS, Haendel MA, Kennedy DN, Hill S, Hof PR, Martone ME, Pols M, Tan SC, Washington N, Zudilova-Seinstra E, Vasilevsky N (2016) The resource identification initiative: a cultural shift in publishing. Brain Behav 6(1):e00417. https://doi.org/10.1002/brb3.417
Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55(4):458–468. https://doi.org/10.1002/ana.20016
Baxi EG, DeBruin J, Tosi DM, Grishkan IV, Smith MD, Kirby LA, Strasburger HJ, Fairchild AN, Calabresi PA, Gocke AR (2015) Transfer of myelin-reactive 17th cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice. J Neurosci 35(22):8626–8639. https://doi.org/10.1523/jneurosci.3817-14.2015
Benakis C, Llovera G, Liesz A (2018) The meningeal and choroidal infiltration routes for leukocytes in stroke. Ther Adv Neurol Disord 11:1756286418783708. https://doi.org/10.1177/1756286418783708
Bonetti B, Raine CS (1997) Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann Neurol 42(1):74–84. https://doi.org/10.1002/ana.410420113
Boretius S, Escher A, Dallenga T, Wrzos C, Tammer R, Bruck W, Nessler S, Frahm J, Stadelmann C (2012) Assessment of lesion pathology in a new animal model of MS by multiparametric MRI and DTI. Neuroimage 59(3):2678–2688. https://doi.org/10.1016/j.neuroimage.2011.08.051
Chrzanowski U, Bhattarai S, Scheld M, Clarner T, Fallier-Becker P, Beyer C, Rohr SO, Schmitz C, Hochstrasser T, Schweiger F, Amor S, Horn-Bochtler A, Denecke B, Nyamoya S, Kipp M (2019) Oligodendrocyte degeneration and concomitant microglia activation directs peripheral immune cells into the forebrain. Neurochem Int. https://doi.org/10.1016/j.neuint.2019.03.005
Clarner T, Janssen K, Nellessen L, Stangel M, Skripuletz T, Krauspe B, Hess FM, Denecke B, Beutner C, Linnartz-Gerlach B, Neumann H, Vallieres L, Amor S, Ohl K, Tenbrock K, Beyer C, Kipp M (2015) CXCL10 triggers early microglial activation in the cuprizone model. J Immunol 194(7):3400–3413. https://doi.org/10.4049/jimmunol.1401459
Draheim T, Liessem A, Scheld M, Wilms F, Weissflog M, Denecke B, Kensler TW, Zendedel A, Beyer C, Kipp M, Wruck CJ, Fragoulis A, Clarner T (2016) Activation of the astrocytic Nrf2/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model. Glia 64(12):2219–2230. https://doi.org/10.1002/glia.23058
Emerson MR, Biswas S, LeVine SM (2001) Cuprizone and piperonyl butoxide, proposed inhibitors of T-cell function, attenuate experimental allergic encephalomyelitis in SJL mice. J Neuroimmunol 119(2):205–213
Faizi M, Salimi A, Seydi E, Naserzadeh P, Kouhnavard M, Rahimi A, Pourahmad J (2016) Toxicity of cuprizone a Cu(2+) chelating agent on isolated mouse brain mitochondria: a justification for demyelination and subsequent behavioral dysfunction. Toxicol Mech Methods 26(4):276–283. https://doi.org/10.3109/15376516.2016.1172284
Fischbach F, Nedelcu J, Leopold P, Zhan J, Clarner T, Nellessen L, Beissel C, van Heuvel Y, Goswami A, Weis J, Denecke B, Schmitz C, Hochstrasser T, Nyamoya S, Victor M, Beyer C, Kipp M (2018) Cuprizone-induced graded oligodendrocyte vulnerability is regulated by the transcription factor DNA damage-inducible transcript 3. Glia. https://doi.org/10.1002/glia.23538
Flatmark T, Kryvi H, Tangeras A (1980) Induction of megamitochondria by cuprizone (biscyclohexanone oxaldihydrazone). Evidence for an inhibition of the mitochondrial division process. Eur J Cell Biol 23(1):141–148
Funfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J, Brinkmann BG, Kassmann CM, Tzvetanova ID, Mobius W, Diaz F, Meijer D, Suter U, Hamprecht B, Sereda MW, Moraes CT, Frahm J, Goebbels S, Nave KA (2012) Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485(7399):517–521. https://doi.org/10.1038/nature11007
Genain CP, Cannella B, Hauser SL, Raine CS (1999) Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med 5(2):170–175. https://doi.org/10.1038/5532
Goldberg J, Daniel M, van Heuvel Y, Victor M, Beyer C, Clarner T, Kipp M (2013) Short-term cuprizone feeding induces selective amino acid deprivation with concomitant activation of an integrated stress response in oligodendrocytes. Cell Mol Neurobiol 33(8):1087–1098. https://doi.org/10.1007/s10571-013-9975-y
Herder V, Hansmann F, Stangel M, Schaudien D, Rohn K, Baumgartner W, Beineke A (2012) Cuprizone inhibits demyelinating leukomyelitis by reducing immune responses without virus exacerbation in an infectious model of multiple sclerosis. J Neuroimmunol 244(1–2):84–93. https://doi.org/10.1016/j.jneuroim.2012.01.010
Hesse A, Wagner M, Held J, Bruck W, Salinas-Riester G, Hao Z, Waisman A, Kuhlmann T (2010) In toxic demyelination oligodendroglial cell death occurs early and is FAS independent. Neurobiol Dis 37(2):362–369. https://doi.org/10.1016/j.nbd.2009.10.016
Hochstrasser T, Exner GL, Nyamoya S, Schmitz C, Kipp M (2017) Cuprizone-containing pellets are less potent to induce consistent demyelination in the corpus callosum of C57BL/6 mice. J Mol Neurosci 61(4):617–624. https://doi.org/10.1007/s12031-017-0903-3
Iglesias A, Bauer J, Litzenburger T, Schubart A, Linington C (2001) T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 36(2):220–234
Janssen K, Rickert M, Clarner T, Beyer C, Kipp M (2016) Absence of CCL2 and CCL3 ameliorates central nervous system grey matter but not white matter demyelination in the presence of an intact blood–brain barrier. Mol Neurobiol 53(3):1551–1564. https://doi.org/10.1007/s12035-015-9113-6
Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 8(6):e1000412. https://doi.org/10.1371/journal.pbio.1000412
Lassmann H, van Horssen J (2016) Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions. Biochim Biophys Acta 3:506–510. https://doi.org/10.1016/j.bbadis.2015.09.018
Licht-Mayer S, Wimmer I, Traffehn S, Metz I, Bruck W, Bauer J, Bradl M, Lassmann H (2015) Cell type-specific Nrf2 expression in multiple sclerosis lesions. Acta Neuropathol 130(2):263–277. https://doi.org/10.1007/s00401-015-1452-x
Llovera G, Benakis C, Enzmann G, Cai R, Arzberger T, Ghasemigharagoz A, Mao X, Malik R, Lazarevic I, Liebscher S, Erturk A, Meissner L, Vivien D, Haffner C, Plesnila N, Montaner J, Engelhardt B, Liesz A (2017) The choroid plexus is a key cerebral invasion route for T cells after stroke. Acta Neuropathol 134(6):851–868. https://doi.org/10.1007/s00401-017-1758-y
Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (1999) A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 122(Pt 12):2279–2295
Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47(6):707–717
Machado-Santos J, Saji E, Troscher AR, Paunovic M, Liblau R, Gabriely G, Bien CG, Bauer J, Lassmann H (2018) The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells. Brain 141(7):2066–2082. https://doi.org/10.1093/brain/awy151
Mahad D, Ziabreva I, Lassmann H, Turnbull D (2008) Mitochondrial defects in acute multiple sclerosis lesions. Brain 131(Pt 7):1722–1735. https://doi.org/10.1093/brain/awn105
Mana P, Fordham SA, Staykova MA, Correcha M, Silva D, Willenborg DO, Linares D (2009) Demyelination caused by the copper chelator cuprizone halts T cell mediated autoimmune neuroinflammation. J Neuroimmunol 210(1–2):13–21. https://doi.org/10.1016/j.jneuroim.2009.02.013
McDonald JW, Althomsons SP, Hyrc KL, Choi DW, Goldberg MP (1998) Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 4(3):291–297
Peferoen L, Kipp M, van der Valk P, van Noort JM, Amor S (2014) Oligodendrocyte-microglia cross-talk in the central nervous system. Immunology 141(3):302–313. https://doi.org/10.1111/imm.12163
Popescu BF, Pirko I, Lucchinetti CF (2013) Pathology of multiple sclerosis: where do we stand? Continuum (Minneap Minn) 19(4 Multiple Sclerosis):901–921. https://doi.org/10.1212/01.CON.0000433291.23091.65
Raine CS, Scheinberg L, Waltz JM (1981) Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion. Lab Investig 45(6):534–546
Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, Lira S, Uccelli A, Lanzavecchia A, Engelhardt B, Sallusto F (2009) C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 10(5):514–523. https://doi.org/10.1038/ni.1716
Ruther BJ, Scheld M, Dreymueller D, Clarner T, Kress E, Brandenburg LO, Swartenbroekx T, Hoornaert C, Ponsaerts P, Fallier-Becker P, Beyer C, Rohr SO, Schmitz C, Chrzanowski U, Hochstrasser T, Nyamoya S, Kipp M (2017) Combination of cuprizone and experimental autoimmune encephalomyelitis to study inflammatory brain lesion formation and progression. Glia 65(12):1900–1913. https://doi.org/10.1002/glia.23202
Scheld M, Ruther BJ, Grosse-Veldmann R, Ohl K, Tenbrock K, Dreymuller D, Fallier-Becker P, Zendedel A, Beyer C, Clarner T, Kipp M (2016) Neurodegeneration triggers peripheral immune cell recruitment into the forebrain. J Neurosci 36(4):1410–1415. https://doi.org/10.1523/jneurosci.2456-15.2016
Schlager C, Korner H, Krueger M, Vidoli S, Haberl M, Mielke D, Brylla E, Issekutz T, Cabanas C, Nelson PJ, Ziemssen T, Rohde V, Bechmann I, Lodygin D, Odoardi F, Flugel A (2016) Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid. Nature 530(7590):349–353. https://doi.org/10.1038/nature16939
Schmidt T, Awad H, Slowik A, Beyer C, Kipp M, Clarner T (2013) Regional heterogeneity of cuprizone-induced demyelination: topographical aspects of the midline of the corpus callosum. J Mol Neurosci 49(1):80–88. https://doi.org/10.1007/s12031-012-9896-0
Scolding NJ, Jones J, Compston DA, Morgan BP (1990) Oligodendrocyte susceptibility to injury by T-cell perforin. Immunology 70(1):6–10
Shojaee S, Chan LN, Buchner M, Cazzaniga V, Cosgun KN, Geng H, Qiu YH, von Minden MD, Ernst T, Hochhaus A, Cazzaniga G, Melnick A, Kornblau SM, Graeber TG, Wu H, Jumaa H, Muschen M (2016) PTEN opposes negative selection and enables oncogenic transformation of pre-B cells. Nat Med 22(4):379–387. https://doi.org/10.1038/nm.4062
Slowik A, Schmidt T, Beyer C, Amor S, Clarner T, Kipp M (2015) The sphingosine 1-phosphate receptor agonist FTY720 is neuroprotective after cuprizone-induced CNS demyelination. Br J Pharmacol 172(1):80–92. https://doi.org/10.1111/bph.12938
van der Valk P, Amor S (2009) Preactive lesions in multiple sclerosis. Curr Opin Neurol 22(3):207–213. https://doi.org/10.1097/WCO.0b013e32832b4c76
Wolburg H, Paulus W (2010) Choroid plexus: biology and pathology. Acta Neuropathol 119(1):75–88. https://doi.org/10.1007/s00401-009-0627-8
Acknowledgements
This work was supported by the Deutsche Forschungsgemeinschaft (KI 1469/8-1; MK). We thank Astrid Baltruschat, Beate Aschauer, Barbara Mosler, Sabine Tost, Sibylle Kerling and Sarah Wübbel for their excellent and valuable technical assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Yakimov, V., Schweiger, F., Zhan, J. et al. Continuous cuprizone intoxication allows active experimental autoimmune encephalomyelitis induction in C57BL/6 mice. Histochem Cell Biol 152, 119–131 (2019). https://doi.org/10.1007/s00418-019-01786-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00418-019-01786-4